newsfilter
← Latest News
PR Newswire·

AcelRx Pharmaceuticals Announces the European Launch of DZUVEO by its Partner, Aguettant

Physicians across Europe will now have access to DZUVEO®, a novel sublingual approach to acute pain management in medically supervised settings HAYWARD, Calif., Oct. 27, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals,